BITTO, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 358
EU - Europa 348
AS - Asia 117
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 825
Nazione #
US - Stati Uniti d'America 355
IE - Irlanda 115
SE - Svezia 103
IT - Italia 70
CN - Cina 61
SG - Singapore 37
PL - Polonia 12
GB - Regno Unito 11
IN - India 11
AT - Austria 8
DE - Germania 8
BE - Belgio 7
FI - Finlandia 7
CA - Canada 3
CH - Svizzera 3
ID - Indonesia 3
LT - Lituania 3
HK - Hong Kong 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
FR - Francia 1
TR - Turchia 1
Totale 825
Città #
Dublin 115
Chandler 114
Nyköping 59
Ashburn 36
Singapore 30
Beijing 22
Dearborn 16
Medford 16
Princeton 16
Warsaw 12
Des Moines 11
Jinan 8
Pune 8
Vienna 8
Brussels 7
Foggia 7
Jacksonville 7
Lamézia 5
Palermo 5
San Mateo 5
Boardman 4
Cambridge 4
Milan 4
Munich 4
Shenyang 4
Wilmington 4
Ann Arbor 3
Caltagirone 3
Helsinki 3
Jakarta 3
Messina 3
Seattle 3
Taiyuan 3
Bologna 2
Bremen 2
Cagliari 2
Cosenza 2
Dong Ket 2
Espoo 2
Frankfurt am Main 2
Hangzhou 2
Hebei 2
Lappeenranta 2
Los Angeles 2
Minneapolis 2
Rome 2
Toronto 2
Zhengzhou 2
Arzano 1
Bengaluru 1
Birmingham 1
Carugo 1
Catania 1
Changsha 1
Haikou 1
Istanbul 1
Jiaxing 1
Lanzhou 1
London 1
Maceió 1
Nanchang 1
Nanjing 1
Napoli 1
Newark 1
Ningbo 1
Norwalk 1
Redwood City 1
Salerno 1
Santarcangelo 1
Shanghai 1
Tianjin 1
Washington 1
Woodbridge 1
Totale 607
Nome #
Inter-observer and intra-observer agreement in diagnosis of type 2 Brugada Pattern 85
Left atrial function in patients undergoing chemotherapy: additional value of 2D longitudinal strain 70
EFFECT OF 1-YEAR SACUBITRIL-VALSARTAN TREATMENT ON MYOCARDIAL DEFORMATION AND LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH CONGESTIVE HEART FAILURE 68
Takotsubo syndrome: prognostic predictors 66
Cardiac implantable devices and Takotsubo syndrome. A rare but potential eventuality 57
Effect of 1-year sacubitril-valsartan treatment on myocardial deformation and left ventricular ejection fraction in patients with congestive heart failure 54
Inter-observer and intra-observer agreement in diagnosis of type 2 brugada pattern 54
Takotsubo Cardiomyopathy: a benign condition or a bad omen? 48
Trend of perceived quality of life and functional capacity in outpatients with chronic heart failure and in treatment with sacubitril/valsartan: a real-life experience. 47
null 44
Diagnosis of type 2 Brugada pattern: insights from a pilot survey 40
Prevalence, predictors and prognostic impact of reverse left ventricular remodelling in outpatients with heart failure with reduced ejection fraction treated with sacubitril/valsartan. A real world study 35
Treatment with sacubitril/valsartan is associated with hemodynamic improvement in outpatients with heart failure with reduced ejection fraction: an echocardiographic study 35
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan. 32
Cardiovascular risk in psoriasis: current state of the art 32
Time-based clinical and functional achievements in real-life HF patients on ARNI treatment 30
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 26
null 23
null 18
null 8
Totale 872
Categoria #
all - tutte 4.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 0 0 0 0 8 7 9 7 2 16 15 8
2020/202195 1 2 18 6 22 4 8 6 11 7 5 5
2021/2022137 0 13 4 10 5 0 6 5 5 39 7 43
2022/2023367 25 49 17 29 25 35 8 22 148 1 4 4
2023/202499 8 18 4 8 5 24 1 11 0 3 4 13
2024/202572 7 7 6 21 31 0 0 0 0 0 0 0
Totale 872